|
This report is being submitted to relay additional information and device evaluation.One full osseotite tapered certain implant 3.25 x 10mm (ifnt3210) was returned for investigation.No malfunction identified.Product inspected and filed.Implant had signs use.Measurements match drawing.No damage identified or signs of malfunction that would contribute to the event.Infection could not be verified.Based on the evaluation and dimensional analysis, device malfunction has not occurred.Additionally, there is no existing nonconformance / capa / hhe/d / ie / product hold against the reported devices that did or could cause or contribute to the reported event.Monthly post market trending review identified no adverse events or actionable trends for the reported event or devices.Zimvie quality management system (qms) has controls in place to ensure the distribution of conforming products.Therefore, based on the available information, the product was within specifications and conforming when it left zimvie.Dhr review for the lot number (2019090852) had revealed no deviations nor non-conformances which could have caused or contributed to the reported event.Products was conforming at the time it left zimvie.Lot was inspected and passed all acceptance criteria by qa.All sterilization activities were conducted with no nonconformities per sterilization record (op0210).Zimvie quality management system (qms) has controls in place to ensure the distribution of conforming products within specifications.Complaint history review was performed for the reported lot number (2019090852) for similar events and one other complaint was identified.Investigation has identified that the most likely probable causes are related to medical conditions/patient habits and surgical technique.Based on the investigation, risk review and ifu, the most likely cause determined from the investigation is clinician places implant in a patient with patient factors (e.G.Poor hygiene, periodontal issues, pre-existing medical conditions) or inadequate treatment planning.No further investigation or immediate capa / hhe/d escalation is required, as the complaint investigation did not confirm the products were nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.
|